Western blot assays showed that heme carrier protein 1 (HCP1), localized to the apical membrane for heme transport, was markedly elevated in NASH livers [22], and its level was normalized by cilostazol administration (Figure 5B). This evidence concerns the gene SLC46A1 and metabolic dysfunction-associated steatohepatitis.